Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows

from Rx for Biotech · host Podcast Host Chris Leidli

OncoOne is a biotech company developing novel therapeutics for patients with solid tumors and autoimmune diseases. In this podcast episode, Brent Meadows, Chief Business Officer and US General Manager, discusses the role of oxMIF in innate and adaptive immunity and outlines the company's development approach and plan for entering the clinic.

Episode metadata supplied by the publisher feed · Published Dec 7, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows

0:00 28:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 28 minutes long.

When was this Rx for Biotech episode published?

This episode was published on December 7, 2022.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!